Ultragenyx Pharmaceutical Inc. Profile Avatar - Palmy Investing

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internat…
Biotechnology
US, Novato [HQ]
Government, Law & Regulation

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Ultragenyx Pharmaceutical Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

Ultragenyx Pharmaceutical Inc. can't present spending by time.

Contract Analysis

There are no contract award details available for Ultragenyx Pharmaceutical Inc.

End of RARE's Analysis
CIK: 1515673 CUSIP: 90400D108 ISIN: US90400D1081 LEI: - UEI: -
Secondary Listings
RARE has no secondary listings inside our databases.